NDC 0093-3656 – Buprenorphine
Buprenorphine 5 ug/h · Patch, Extended Release · Transdermal
Product NDC0093-3656
Product details
- Brand name
- Buprenorphine
- Generic name
- Buprenorphine
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- Patch, Extended Release
- Route
- Transdermal
- Marketing category
- ANDA · ANDA204937
- Marketed since
- November 26, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- Partial Opioid Agonist
Active ingredients
- Buprenorphine 5 ug/h
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0093-3656-40 | 4 POUCH in 1 CARTON (0093-3656-40) / 1 PATCH in 1 POUCH / 168 h in 1 PATCH | Nov 26, 2018 |
Recalls mentioning this NDC
- D-0003-2021 Oct 7, 2020 · Class II
Failed Stability Specifications: Below specification result for buprenorphine release rate.
Other Buprenorphine products
- 69238-1203 Buprenorphine 10 ug/h · Patch, Extended Release · Amneal Pharmaceuticals NY LLC
- 69238-1205 Buprenorphine 20 ug/h · Patch, Extended Release · Amneal Pharmaceuticals NY LLC
- 69238-1202 Buprenorphine 5 ug/h · Patch, Extended Release · Amneal Pharmaceuticals NY LLC
- 69238-1204 Buprenorphine 15 ug/h · Patch, Extended Release · Amneal Pharmaceuticals NY LLC
- 69238-1505 Buprenorphine 7.5 ug/h · Patch, Extended Release · Amneal Pharmaceuticals NY LLC
- 3215-1525 Buprenorphine 20 ug/h · Patch, Extended Release · Aveva Drug Delivery Systems Inc.
- 3215-1524 Buprenorphine 15 ug/h · Patch, Extended Release · Aveva Drug Delivery Systems Inc.
- 3215-1521 Buprenorphine 5 ug/h · Patch, Extended Release · Aveva Drug Delivery Systems Inc.
- 3215-1522 Buprenorphine 7.5 ug/h · Patch, Extended Release · Aveva Drug Delivery Systems Inc.
- 3215-1523 Buprenorphine 10 ug/h · Patch, Extended Release · Aveva Drug Delivery Systems Inc.
- 50742-375 Buprenorphine 15 ug/h · Patch, Extended Release · INGENUS PHARMACEUTICALS, LLC
- 50742-373 Buprenorphine 7.5 ug/h · Patch, Extended Release · INGENUS PHARMACEUTICALS, LLC